# iBio, Inc.: Form 8-K, filed Oct 19, 2026

- Company: [iBio, Inc.](/companies/ibio.md) (CIK 1420720)
- Form: 8-K
- Filed: 2026-10-19
- Accepted by EDGAR: Oct 19, 2026, 16:16 ET
- Period: 2026-10-14
- Accession: 0001420720-26-000032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1420720/000142072026000032/ibio-20261014x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1420720/000142072026000032/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1420720/000142072026000032/ibio-20261014x8k.htm

Filed Oct 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001420720-26-000032. Last ingested by Listed: Nov 11, 2026, 02:10 ET. No prices; not investment advice.
